Relationship between socioeconomic level, and the prevalence of masked hypertension and asymptomatic organ damage

Medical Science Monitor

Volumn 21, Issue , 2015, Pages 1022-1030

  Ateş, İhsan ^a   Altay, Mustafa ^a   Kaplan, Mustafa ^a   Ozkayar, Nihal ^a   Toprak, Güvenc ^a   Alagüney, M Erdem ^a   Özkara, Adem ^a,b  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b HITIT UNIVERSITY   (Turkey)

Author keywords

Hypertension; Masked hypertension; Socioeconomic factors

Indexed keywords

ALBUMIN; CHOLESTEROL; CREATININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; ASYMPTOMATIC DISEASE; CARDIOVASCULAR PARAMETERS; COLORIMETRY; ECHOCARDIOGRAPHY; ELEVATED BLOOD PRESSURE; ESSENTIAL HYPERTENSION; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HUMAN; LEFT VENTRICULAR MASS INDEX; MAJOR CLINICAL STUDY; MALE; MASKED HYPERTENSION; MICROALBUMINURIA; MIDDLE AGED; OPHTHALMOSCOPY; ORGAN INJURY; RETROSPECTIVE STUDY; SMOKING; SOCIOECONOMICS; ANTIBODY SPECIFICITY; DEMOGRAPHY; HEART VENTRICLE; MULTIVARIATE ANALYSIS; ORGAN SIZE; PATHOLOGY; PREVALENCE; REGRESSION ANALYSIS; TURKEY;

CAROTID INTIMA-MEDIA THICKNESS; DEMOGRAPHY; FEMALE; HEART VENTRICLES; HUMANS; MALE; MASKED HYPERTENSION; MIDDLE AGED; MULTIVARIATE ANALYSIS; ORGAN SIZE; ORGAN SPECIFICITY; PREVALENCE; REGRESSION ANALYSIS; SOCIOECONOMIC FACTORS; TURKEY;

EID: 84926483177     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.892684     Document Type: Article

References (22)

1. Pickering TG, Davidson K, Gerin W, Schwartz JE: Masked hypertension. Hypertension, 2002; 40(6): 795–96
2. Konstantopoulou AS, Papargyrio IK, Antonıadou ES et al: Masked hypertension: a new entity under investigation. Hellenic J Cardiol, 2006; 47(4): 232–35
3. Mancia G, Fagard R, Narkiewicz K et al: 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J, 2013; 34(28): 2159–219
4. Liu JE, Roman MJ, Pini R et al: Cardiac and arterial target organ damage in adults with elevated ambulatory and normal office blood pressure. Ann Intern Med, 1999; 131(8): 564–72
5. Sega R, Trocino G, Lanzarotti A et al: Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: Data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study). Circulation, 2001; 104(12): 1385–92
6. Papadopoulos DP, Makris TK: Masked hypertension definition, impact, outcomes: a critical review. J Clin Hypertens (Greenwich), 2007; 9(12): 956–63
7. Tomiyama M, Horio T, Yoshii M et al: Masked hypertension and target organ damage in treated hypertensive patients. Am J Hypertens, 2006; 19(9): 880–86
8. Bacaksiz A, Erdogan E, Sonmez O et al: Ambulatory blood pressure monitoring can unmask hypertension in patients with psoriasis vulgaris. Med Sci Monit, 2013; 19: 501–9
9. O’Brien E, Atkins N, Stergiou G et al: European Society of Hypertension International Protocol revision 2010 for the validation of blood pressure measuring devices in adults. Blood Press Monit, 2010; 15(1): 23–38
10. Devereux RB, Reichek N: Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation, 1977; 55(4): 613–18
11. Grabysa R, Wankowicz Z: Echocardiographic markers of left ventricular dysfunction among men with uncontrolled hypertension and stage 3 chronic kidney disease. Med Sci Monit, 2013; 19: 838–45
12. Mieczkowska J, Mosiewicz J, Sak J et al: Effects of cigarette smoking, metabolic syndrome and dehydroepiandrosterone deficiency on intima-media thickness and endothelial function in hypertensive postmenopausal women. Med Sci Monit, 2012; 18(4): CR225–34
13. Pignoli P, Tremoli E, Poli A et al: Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation, 1986; 74(6): 1399–406
14. Levey AS, Stevens LA, Schmid CH et al: A new equation to estimate glomerular filtration rate. Ann Intern Med, 2009; 150(9): 604–12
15. Imai Y, Tsuji I, Nagai K et al: Ambulatory blood pressure monitoring in evaluating the prevalence of hypertension in adults in Ohasama, a rural Japanese community. Hypertens Res, 1996; 19(3): 207–12
16. Belkic KL, Schnall PL, Landsbergis PA et al: Hypertension at the workplace – an occult disease? The need for work site surveillance. Adv Psychosom Med, 2001; 22: 116–38
17. Charvat J, Chlumsky J, Szabo M et al: The association of masked hypertension in treated type 2 diabetic patients with carotid artery IMT. Diabetes Res Clin Pract, 2010; 89(3): 239–42
18. Yoon HJ, Ahn Y, Park JB et al: Are metabolic risk factors and target organ damage more frequent in masked hypertension than in white coat hypertension? Clin Exp Hypertens, 2010; 32(7): 480–85
19. Kotsis V, Stabouli S, Toumanidis S et al: Target organ damage in “white coat hypertension” and “masked hypertension”. Am J Hypertens, 2008; 21(4): 393–99
20. Konstantopoulou AS, Konstantopoulou PS, Papargyriou IK et al: Masked, white coat and sustained hypertension: comparison of target organ damage and psychometric parameters. J Hum Hypertens, 2010; 24(3): 151–57
21. Rodrigo R, Gonzalez J, Paoletto F: The role of oxidative stress in the pathophysiology of hypertension. Hypertens Res, 2011; 34(4): 431–40
22. Kawano Y, Horio T, Matayoshi T, Kamide K: Masked hypertension: subtypes and target organ damage. Clin Exp Hypertens, 2008; 30(3): 289–96